Generic Name and Formulations:
Naproxen sodium 220mg, pseudoephedrine HCl 120mg; ext-rel tabs; contains sodium 22mg/caplet.
- Undifferentiated Headaches Common in Children, Adolescents
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Short-Term Benefit for Alzheimer Disease Psychosis With Pimavanserin
- Pharmacological Migraine Prophylaxis Guidelines
- Antipyretic Medications
- Alzheimer's Dementia Treatments
Indications for ALEVE-D:
Nasal congestion, sinus pressure, headache, fever, minor aches and pains.
Swallow whole. Take with fluids. 1 caplet every 12hrs. Max 2 caplets/24hrs.
<12yrs: not recommended.
Aspirin allergy. During or within 14 days of MAOIs. Immediately before or after cardiac surgery.
Increased risk of severe stomach bleeding (esp. ≥60yrs old). History of GI disorders (eg, heartburn, bleeding ulcers). Increased risk of heart attack or failure, and stroke. Hypertension. Heart disease. Recent stroke. Liver cirrhosis. Renal disease. Asthma. Dehydration. Diabetes. GU obstruction. Reevaluate if nasal congestion worsens or lasts >7 days or fever persists or worsens >3 days. Elderly. Pregnancy (avoid during 3rd trimester). Nursing mothers: not recommended.
Hypertensive crisis with MAOIs (see Contraindications). β-blockers may increase pressor effects of sympathomimetics. May potentiate anticoagulants, CNS stimulants. Avoid aspirin or other pain relievers. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx NSAID-containing products (eg, ibuprofen, naproxen, others), ≥3 alcoholic drinks/day, or prolonged use. Caution with diuretics.
NSAID (arylacetic acid deriv.) + sympathomimetic.
Nervousness, dizziness, insomnia; GI upset/bleed, feel faint, rash, redness, difficulty swallowing, symptoms of heart problems or stroke (eg, trouble breathing, chest pain, weakness, slurred speech, leg swelling), allergic reactions; discontinue if occur.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Predicting Seizure Risk Following Ischemic Stroke With SeLECT Score
- Surgical Outcomes Associated With Trigger Site Deactivation for Migraines
- Combined Exercise Training Increases BDNF in Relapsing-Remitting MS
- Exome-Targeted Capture Sequencing Can Diagnose Previously-Undetected Ataxia
- Strategies for Preventing and Treating Delirium
- High Total Cholesterol Neuroprotective Against Cognitive Decline